Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search


Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • News item (12)
  • Page (12)
  • Subject (7)
  • Blog post (5)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) December 2025 (21)
  • (-) May 2021 (15)
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (9)
  • November 2025 (16)
  • October 2025 (11)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • June 2025 (8)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (20)
  • December 2024 (13)
  • November 2024 (7)
  • October 2024 (10)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • March 2024 (10)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (19)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (11)
  • August 2022 (10)
  • July 2022 (18)
  • June 2022 (17)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • February 2022 (7)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • April 2021 (15)
  • March 2021 (12)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (3)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • November 2018 (14)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (4)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • International (8)
  • Nanotechnology and advanced materials (5)
  • Climate change and Health (3)
  • DNA and public health (3)
  • COVID-19 (2)
  • Alternatives to animal testing (1)
  • Flu and flu vaccine (1)
  • Food and Nutrition (1)
  • Infectious Disease Control (1)
  • International projects (1)
  • Mental Health (1)
  • Salmonella (1)
  • Shigellosis (1)

36 search results

You searched for these word(s): risk assessment
  • RISK-HUNT3R

    https://www.rivm.nl/en/international-projects/risk-hunt3r

    … The five-year European project RISK-HUNT3 R will develop a novel and modular framework for animal-free Next Generation Risk Assessment (NGRA).  The principles of the 3Rs are … The aim of the RISK-HUNT3 R project is to better protect citizens against … constituting the research cluster ASPIS (animal-free safety assessment of chemicals: project cluster for implementation …

    Publication date: 05-31-2021
  • Young people aged 16-18 in medical high-risk groups invited for vaccination

    https://www.rivm.nl/en/news/young-people-aged-16-18-in-medical-high-risk-groups-invited-for-vaccination

    … Young people in medical high-risk groups who are living at home will receive an … These young people are included in the medical high-risk group that the Health Council has defined for adults. They have a higher risk of severe illness due to the coronavirus SARS-CoV-2. …

    Publication date: 05-18-2021
  • Mental health at risk: broad investment in mental health by new government required

    https://www.rivm.nl/en/news/mental-health-at-risk-broad-investment-in-mental-health-by-new-government-required

    … Monitor shows that mental health in the Netherlands is at risk and highlights the urgency of the situation. Around 85% … to improve individual well-being and detect mental health risks and problems at an early stage. If problems do arise, … Mental health at risk: broad investment in mental health by new government …

    Publication date: 12-12-2025
  • Quality assessment of SARS-CoV-2 antigen test diagnostics: good performance at public test sites in the Netherlands

    https://www.rivm.nl/en/news/quality-assessment-of-sars-cov-2-antigen-test-diagnostics-good-performance-at-public-test

    … of virus in a sample. If a workflow involves visual assessment of the results, it can be difficult to detect the … of the virus at all times. Proper training in visual assessment of results is therefore recommended. … Quality assessment of SARS-CoV-2 antigen test diagnostics: good …

    Publication date: 05-27-2021
  • First people with medical risk invited for vaccination

    https://www.rivm.nl/en/news/first-people-with-medical-risk-invited-for-vaccination

    … for the seasonal flu vaccination. They have an additional risk of becoming ill due to COVID-19. Starting on 6 May, … First people with medical risk invited for vaccination …

    Publication date: 05-04-2021
  • Travellers to Cape Verde: be alert to bacterial dysentery caused by shigellosis

    https://www.rivm.nl/en/news/travellers-to-cape-verde-be-alert-to-bacterial-dysentery-caused-by-shigellosis

    … RIVM has warned travellers to Cape Verde about a shigellosis risk. The bacterial infection causes severe bloody diarrhoea … on the Cape Verdean islands. There are certain health risks as a result of the outbreak. Travellers can make an … to shigellosis. Good hygiene can help to minimise the risk: Wash your hands regularly. Flush the toilet with the …

    Publication date: 12-10-2025
  • Early detection and screening

    https://www.rivm.nl/en/dna-and-public-health/early-detection-and-screening

    … identify early on whether someone has a condition or is at risk of developing one. This can be done in different ways. … a genetic predisposition to a disease that increases the risk of disease. For more information on this and RIVM’s … multiple locations on the DNA that are associated with the risk of developing a disease. This means that, in the …

    Publication date: 12-16-2025
  • Responsible innovation with nanomaterials and nanotechnology: past, present, future

    https://www.rivm.nl/en/weblog/responsible-innovation-with-nanomaterials-and-nanotechnology-past-present-future

    … into everyday life accelerates, understanding the risks and benefits of these materials becomes crucial, … and clean energy applications. Balancing benefits and risks is key Understanding how nanomaterials move, … to managing both benefits—like cleaner energy systems—and risks, such as nanoparticle pollution. The overarching …

    Publication date: 12-18-2025
  • Flu vaccine during pregnancy

    https://www.rivm.nl/en/flu-and-flu-vaccine/vaccine/pregnancy

    … Newborn babies have a higher risk of serious consequences from flu, such as hospital … If a pregnant woman gets the flu, she has a higher risk of serious illness than a woman who is not pregnant. … compared to women of the same age who are not pregnant. The risk of ICU admission or death from flu does not seem to …

    Publication date: 12-19-2025
  • Infectious diseases

    https://www.rivm.nl/en/climate-change-and-health/infectious-diseases

    … when they occur, and their numbers. This also affects the risks of infectious diseases that people in our country can …

    Publication date: 05-10-2021
  • Water

    https://www.rivm.nl/en/climate-change-and-health/water

    … contact with water more frequently, and some related health risks will become more challenging. To reduce these risks and exploit opportunities, RIVM is studying the impact … in the Netherlands and abroad. RIVM is conducting needs assessments, and mapping global health effects of climate …

    Publication date: 05-10-2021
  • New approach methodologies to study intestinal fate of nanomaterials: current understanding and knowledge gaps

    https://www.rivm.nl/en/weblog/new-approach-methodologies-to-study-intestinal-fate-of-nanomaterials-current-understanding

    … knowledge gaps remain, especially in standardising and assessing how well these models mimic human biology and … human health. The intestinal uptake of NMs is critical for assessing their systemic effects. The intestine serves as a … strengthen the scientific and regulatory foundations for assessing the intestinal fate of ingested NMs. The document …

    Publication date: 12-18-2025
  • Machine learning to identify key factors in titanium dioxide nanoparticle genotoxicity; a work in progress

    https://www.rivm.nl/en/weblog/machine-learning-to-identify-key-factors-in-titanium-dioxide-nanoparticle-genotoxicity-work

    … handling outliers and validating the model warrants further assessment. The findings of this study are therefore not … presents an interesting approach that uses ML for hazard assessment. If developed further, these methods could be valuable for hazard and risk assessment. However, in its current set-up, the …

    Publication date: 12-18-2025
  • Issue 18

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/18

    … aged 16-18 years living at home who are in medical high-risk groups are now also invited to get vaccinated, and will … between the two vaccines. This is primarily related to assessment of any adverse events or allergic reactions. See …

    Publication date: 05-25-2021
  • Transforming waste into valuable resources: innovations in sustainable nanoparticle synthesis

    https://www.rivm.nl/en/weblog/transforming-waste-into-valuable-resources-innovations-in-sustainable-nanoparticle-synthesis

    … Consequently, the existing issues surrounding their risk assessment remain, including knowledge gaps on long-term …

    Publication date: 12-18-2025
  • Issue 17

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/17

    … or Moderna vaccine. See our webpage on medical risk groups and high-risk groups for more information. Frequently asked questions …

    Publication date: 05-10-2021
  • Climate change and Health

    https://www.rivm.nl/en/climate-change-and-health

    … Climate change may affect the risks of infectious diseases, such as legionellosis, Lyme …

    Publication date: 05-10-2021
  • Research, innovation and development

    https://www.rivm.nl/en/dna-and-public-health/research-innovation-and-development

    … called genetic variants, that can increase or reduce the risk of developing a condition. RIVM has  studied (in Dutch) … there are DNA tests that can properly predict the risk of developing them. Furthermore, the recommended lifestyle advice for someone with an increased risk of developing a condition is often the same as general …

    Publication date: 12-16-2025
  • Improved air quality leads to decline in mortality

    https://www.rivm.nl/en/news/improved-air-quality-leads-to-decline-in-mortality

    … individual substances The comparison also revealed that the risk of death after being exposed to a similar quantity of … matter or ozone has not changed. For nitrogen dioxide, this risk seems to have gotten smaller. The reasons for this are … research is needed to examine which people are at a greater risk of dying after multiple days of elevated concentrations …

    Publication date: 12-11-2025
  • RIVM launches study on long-term effectiveness of COVID-19 vaccines

    https://www.rivm.nl/en/news/rivm-launches-study-on-long-term-effectiveness-of-covid-19-vaccines

    … different vaccines, both in the general population and in risk groups. VASCO will be conducted by RIVM in conjunction … involve limited research on the effect of the vaccines in risk groups, such as the elderly or people with underlying … both in healthy people and in individuals who are in risk groups. Study design All Dutch residents aged 18 …

    Publication date: 05-10-2021

Pagination

  • Current page 1
  • Page 2
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Huisregels sociale media

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon